Heptagon Fund ICAV - Driehaus US Micro Cap Equity Fund AE EUR AccRegistrati per vedere i rating |
Storico dei rendimenti | 31/10/2024 |
Crescita di 1000 (EUR) | Grafico Interattivo |
Sintesi | ||
NAV 20/11/2024 | EUR 279,495 | |
Var.Ultima Quotazione | 0,89% | |
Categoria Morningstar™ | Azionari USA Small Cap | |
Categoria Assogestioni | - | |
Isin | IE00BDB53389 | |
Fund Size (Mil) 20/11/2024 | USD 935,29 | |
Share Class Size (Mil) 20/11/2024 | EUR 2,29 | |
Entrata (max) | 3,00% | |
Spese correnti 28/03/2024 | 1,70% |
Obiettivo d'Investimento Dichiarato: Heptagon Fund ICAV - Driehaus US Micro Cap Equity Fund AE EUR Acc |
The investment objective of the Fund is to achieve long-term capital growth. The Fund uses a growth style of investment in equity securities, whereby the Sub-Investment Manager seeks out investments with good growth potential. Under normal market conditions, the Fund will invest at least 80% of its net assets in the equity securities, including common and preferred stocks, of U.S. micro-capitalization (“micro-cap”) companies. |
Rendimenti % (EUR) | |||||||||||||
|
Gestione | ||
Nome del Gestore Inizio Gestione | ||
Jeffrey James 07/12/2016 | ||
Michael Buck 07/12/2016 | ||
Click here to see others | ||
Data di Partenza 12/07/2018 |
Pubblicità |
Indice | |
Benchmark Dichiarato | Indice di Categoria Morningstar |
Russell Micro Cap Growth TR USD | Morningstar US Small Extended NR USD |
Target Market | ||||||||||||||||||||
|
Composizione del Fondo Heptagon Fund ICAV - Driehaus US Micro Cap Equity Fund AE EUR Acc | 30/09/2024 |
|
|
Primi 5 Titoli | Settore | % |
Crinetics Pharmaceuticals Inc | Salute | 2,82 |
Construction Partners Inc Class A | Beni industriali | 2,61 |
Modine Manufacturing Co | Beni di consumo ciclici | 2,47 |
TransMedics Group Inc | Salute | 2,28 |
ADMA Biologics Inc | Salute | 1,90 |
Incremento Decremento Nuova Posizione | ||
Heptagon Fund ICAV - Driehaus US Micro Cap Equity Fund AE EUR Acc |